Skip to content
About
Menu Toggle
Our Story
Leadership
Board of Directors
Research Leadership
Development Leadership
Scientific Advisory Board
Bezuclastinib
Menu Toggle
Our Approach
About Systemic Mastocytosis
About GIST
Our Clinical Trials
Our Expanded Access Policy
Careers
Menu Toggle
Why Cogent
Our Team
What We Offer
Our Open Roles
Recruiting Scam Alert
Pipelines & Research Targets
Menu Toggle
Pipeline
Posters & Publications
Patients & Families
Menu Toggle
Patients & Families
Gastrointestinal Stromal Tumors (GIST)
Systemic Mastocytosis (SM)
Investors & Media
Menu Toggle
Company Profile
Press Releases
Events
Presentations
Analyst Coverage
Corporate Governance
SEC Filings
Investor Resources
Main Menu
About
Menu Toggle
Our Story
Leadership
Board of Directors
Research Leadership
Development Leadership
Scientific Advisory Board
Bezuclastinib
Menu Toggle
Our Approach
About Systemic Mastocytosis
About GIST
Our Clinical Trials
Our Expanded Access Policy
Careers
Menu Toggle
Why Cogent
Our Team
What We Offer
Our Open Roles
Recruiting Scam Alert
Pipelines & Research Targets
Menu Toggle
Pipeline
Posters & Publications
Patients & Families
Menu Toggle
Patients & Families
Gastrointestinal Stromal Tumors (GIST)
Systemic Mastocytosis (SM)
Investors & Media
Menu Toggle
Company Profile
Press Releases
Events
Presentations
Analyst Coverage
Corporate Governance
SEC Filings
Investor Resources
About
Menu Toggle
Our Story
Leadership
Board of Directors
Research Leadership
Development Leadership
Scientific Advisory Board
Bezuclastinib
Menu Toggle
Our Approach
About Systemic Mastocytosis
About GIST
Our Clinical Trials
Our Expanded Access Policy
Careers
Menu Toggle
Why Cogent
Our Team
What We Offer
Our Open Roles
Recruiting Scam Alert
Pipelines & Research Targets
Menu Toggle
Pipeline
Posters & Publications
Patients & Families
Menu Toggle
Patients & Families
Gastrointestinal Stromal Tumors (GIST)
Systemic Mastocytosis (SM)
Investors & Media
Menu Toggle
Company Profile
Press Releases
Events
Presentations
Analyst Coverage
Corporate Governance
SEC Filings
Investor Resources
Main Menu
About
Menu Toggle
Our Story
Leadership
Board of Directors
Research Leadership
Development Leadership
Scientific Advisory Board
Bezuclastinib
Menu Toggle
Our Approach
About Systemic Mastocytosis
About GIST
Our Clinical Trials
Our Expanded Access Policy
Careers
Menu Toggle
Why Cogent
Our Team
What We Offer
Our Open Roles
Recruiting Scam Alert
Pipelines & Research Targets
Menu Toggle
Pipeline
Posters & Publications
Patients & Families
Menu Toggle
Patients & Families
Gastrointestinal Stromal Tumors (GIST)
Systemic Mastocytosis (SM)
Investors & Media
Menu Toggle
Company Profile
Press Releases
Events
Presentations
Analyst Coverage
Corporate Governance
SEC Filings
Investor Resources
Scroll to Top
